Galectin-1 augments Ras activation and diverts Ras signals to Raf-1 at the expense of phosphoinositide 3-kinase

被引:181
作者
Elad-Sfadia, G
Haklai, R
Ballan, E
Gabius, HJ
Kloog, Y [1 ]
机构
[1] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel
[2] Univ Munich, Fac Med Vet, Inst Physiol Chem, D-80539 Munich, Germany
关键词
D O I
10.1074/jbc.M205698200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ras proteins activate diverse effector molecules. Depending on the cellular context, Ras activation may have different biological consequences: induction of cell proliferation, senescence, survival, or death. Augmentation and selective activation of particular effector molecules may underlie various Ras actions. In fact, Ras effector-loop mutants interacting with distinctive effectors provide evidence for such selectivity. Interactions of active Ras with escort proteins, such as galectin-1, could also direct Ras selectivity. Here we show that in comparison with Ras transfectants, H-Ras/galectin-1 or K-Ras4B/galectin-1 co-transfectants exhibit enhanced and prolonged epidermal growth factor (EGF)-stimulated increases in Ras-GTP, Raf-1 activity, and active extracellular signal-regulated kinase. Galectin-1 antisense RNA inhibited these EGF responses. Conversely, Ras and galectin-1 co-transfection inhibited the EGF-stimulated increase in phosphoinositide 3-kinase (PI3K) activity. Galectin-1 transfection also inhibited Ras(G12V)-induced PI3K but not Raf-1 activity. Galectin-1 co-immunoprecipitated with Ras(G12V) or with Ras(G12V/T35S) that activate Raf-1 but not with Ras(G12V/ Y40C) that activates PI3K. Thus, galectin-1 binds active Ras and diverts its signal to Raf-1 at the expense of PI3K. This demonstrates a novel mechanism controlling the duration and selectivity of the Ras signal. Ras gains selectivity when it is associated with galectin-1, mimicking the selectivity of Ras(T35S), which activates Raf-1 but not PI3K.
引用
收藏
页码:37169 / 37175
页数:7
相关论文
共 47 条
[1]   Galectins-1 and-3 and their ligands in tumor biology -: Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity [J].
André, S ;
Kojima, S ;
Yamazaki, N ;
Fink, C ;
Kaltner, H ;
Kayser, K ;
Gabius, HJ .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1999, 125 (8-9) :461-474
[2]   Ras and Rho GTPases: A family reunion [J].
Bar-Sagi, D ;
Hall, A .
CELL, 2000, 103 (02) :227-238
[3]  
BARONDES SH, 1994, J BIOL CHEM, V269, P20807
[4]   Increasing complexity of Ras signaling [J].
Campbell, SL ;
Khosravi-Far, R ;
Rossman, KL ;
Clark, GJ ;
Der, CJ .
ONCOGENE, 1998, 17 (11) :1395-1413
[5]   P21RAS IS MODIFIED BY A FARNESYL ISOPRENOID [J].
CASEY, PJ ;
SOLSKI, PA ;
DER, CJ ;
BUSS, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (21) :8323-8327
[6]   The C-terminal polylysine region and methylation of K-Ras are critical for the interaction between K-Ras and microtubules [J].
Chen, Z ;
Otto, JC ;
Bergo, MO ;
Young, SG ;
Casey, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (52) :41251-41257
[7]   Endomembrane trafficking of Ras: The CAAX motif targets proteins to the ER and Golgi [J].
Choy, E ;
Chiu, VK ;
Silletti, J ;
Feoktistov, M ;
Morimoto, T ;
Michaelson, D ;
Ivanov, IE ;
Philips, MR .
CELL, 1999, 98 (01) :69-80
[8]   A distinct class of dominant negative Ras mutants - Cytosolic GTP-bound Ras effector domain mutants that inhibit Ras signaling and transformation and enhance cell adhesion [J].
Fiordalis, JJ ;
Holly, SP ;
Johnson, RL ;
Parise, LV ;
Cox, AD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :10813-10823
[9]   Point mutants of c-RAF-1 RBD with elevated binding to v-Ha-Ras [J].
Fridman, M ;
Maruta, H ;
Gonez, J ;
Walker, F ;
Treutlein, H ;
Zeng, J ;
Burgess, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (39) :30363-30371
[10]   Animal lectins [J].
Gabius, HJ .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (03) :543-576